Found: 41
Select item for more details and to access through your institution.
A potent replicative delta-24 adenoviral vector driven by the promoter of human papillomavirus 16 that is highly selective for associated neoplasms.
- Published in:
- Journal of Gene Medicine, 2007, v. 9, n. 10, p. 852, doi. 10.1002/jgm.1071
- By:
- Publication type:
- Article
Corrigendum.
- Published in:
- Oncogene, 2000, v. 19, n. 43, p. 5038
- By:
- Publication type:
- Article
A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo.
- Published in:
- Oncogene, 2000, v. 19, n. 1, p. 2, doi. 10.1038/sj.onc.1203251
- By:
- Publication type:
- Article
Retargeting of adenoviral infection to melanoma: Combining genetic ablation of native tropism with a recombinant bispecific single-chain diabody (scDb) adapter that binds to fiber knob and HMWMAA.
- Published in:
- International Journal of Cancer, 2004, v. 108, n. 1, p. 136, doi. 10.1002/ijc.11563
- By:
- Publication type:
- Article
Mesenchymal Stromal Cells for Linked Delivery of Oncolytic and Apoptotic Adenoviruses to Non-small-cell Lung Cancers.
- Published in:
- Molecular Therapy, 2015, v. 23, n. 9, p. 1497, doi. 10.1038/mt.2015.110
- By:
- Publication type:
- Article
Encapsulated Stem Cells Loaded With Hyaluronidase-expressing Oncolytic Virus for Brain Tumor Therapy.
- Published in:
- Molecular Therapy, 2015, v. 23, n. 1, p. 108, doi. 10.1038/mt.2014.204
- By:
- Publication type:
- Article
A pRb-responsive, RGD-modified, and Hyaluronidase-armed Canine Oncolytic Adenovirus for Application in Veterinary Oncology.
- Published in:
- Molecular Therapy, 2014, v. 22, n. 5, p. 986, doi. 10.1038/mt.2014.7
- By:
- Publication type:
- Article
SWI/SNF Complex Alterations in Tumors with Rhabdoid Features: Novel Therapeutic Approaches and Opportunities for Adoptive Cell Therapy.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 13, p. 11143, doi. 10.3390/ijms241311143
- By:
- Publication type:
- Article
Arming Oncolytic Adenoviruses: Effect of Insertion Site and Splice Acceptor on Transgene Expression and Viral Fitness.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 14, p. 5158, doi. 10.3390/ijms21145158
- By:
- Publication type:
- Article
Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway.
- Published in:
- 2003
- By:
- Publication type:
- journal article
CAR-T Cells and Oncolytic Viruses: Joining Forces to Overcome the Solid Tumor Challenge.
- Published in:
- Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.02460
- By:
- Publication type:
- Article
A novel E1A-E1B mutant adenovirus induces glioma regression in vivo.
- Published in:
- Oncogene, 2004, v. 23, n. 10, p. 1821, doi. 10.1038/sj.onc.1207321
- By:
- Publication type:
- Article
Verapamil Results in Increased Blood Levels of Oncolytic Adenovirus in Treatment of Patients With Advanced Cancer.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 1, p. 221, doi. 10.1038/mt.2011.230
- By:
- Publication type:
- Article
Adenovirus i-Leader Truncation Bioselected Against Cancer-associated Fibroblasts to Overcome Tumor Stromal Barriers.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 1, p. 54, doi. 10.1038/mt.2011.159
- By:
- Publication type:
- Article
Minimal RB-responsive E1A Promoter Modification to Attain Potency, Selectivity, and Transgene-arming Capacity in Oncolytic Adenoviruses.
- Published in:
- Molecular Therapy, 2010, v. 18, n. 11, p. 1960, doi. 10.1038/mt.2010.173
- By:
- Publication type:
- Article
Hyaluronidase Expression by an Oncolytic Adenovirus Enhances Its Intratumoral Spread and Suppresses Tumor Growth.
- Published in:
- Molecular Therapy, 2010, v. 18, n. 7, p. 1275, doi. 10.1038/mt.2010.79
- By:
- Publication type:
- Article
Verapamil Enhances the Antitumoral Efficacy of Oncolytic Adenoviruses.
- Published in:
- Molecular Therapy, 2010, v. 18, n. 5, p. 903, doi. 10.1038/mt.2010.22
- By:
- Publication type:
- Article
Systemic Toxicity–Efficacy Profile of ICOVIR-5, a Potent and Selective Oncolytic Adenovirus Based on the pRB Pathway.
- Published in:
- Molecular Therapy, 2007, v. 15, n. 9, p. 1607, doi. 10.1038/sj.mt.6300239
- By:
- Publication type:
- Article
Oncolytic Adenovirus Expressing a p53 Variant Resistant to Degradation by HPV E6 Protein Exhibits Potent and Selective Replication in Cervical Cancer
- Published in:
- Molecular Therapy, 2005, v. 12, n. 6, p. 1083, doi. 10.1016/j.ymthe.2005.06.443
- By:
- Publication type:
- Article
553. A Potent Replicative Delta Adenoviral Vector for HPV Tumors
- Published in:
- 2005
- By:
- Publication type:
- Abstract
526. Conditionally Replicative Adenoviruses Designed to Restore Defects in the p53 Pathway for Effective Virotherapy of Cancer
- Published in:
- 2005
- By:
- Publication type:
- Abstract
A conditionally replicating adenovirus targeted to tumor cells through activated RAS/P-MAPK-selective mRNA stabilization.
- Published in:
- Nature Biotechnology, 2003, v. 21, n. 7, p. 771, doi. 10.1038/nbt835
- By:
- Publication type:
- Article
Replicative adenoviruses for cancer therapy.
- Published in:
- Nature Biotechnology, 2000, v. 18, n. 7, p. 723, doi. 10.1038/77283
- By:
- Publication type:
- Article
COMBINING PARAMETRIC AND NON-PARAMETRIC METHODS TO COMPUTE VALUE-AT-RISK.
- Published in:
- Economic Computation & Economic Cybernetics Studies & Research, 2016, v. 50, n. 4, p. 61
- By:
- Publication type:
- Article
Tumor cells as cellular vehicles to deliver gene therapies to metastatic tumors.
- Published in:
- Cancer Gene Therapy, 2005, v. 12, n. 4, p. 341, doi. 10.1038/sj.cgt.7700801
- By:
- Publication type:
- Article
Complementary adenoviral vectors for oncolysis.
- Published in:
- Cancer Gene Therapy, 1999, v. 6, n. 1, p. 21, doi. 10.1038/sj.cgt.7700001
- By:
- Publication type:
- Article
SISTEMA PÚBLICO DE DEPENDENCIA Y REDUCCIÓN DEL COSTE INDIVIDUAL DE CUIDADOS A LO LARGO DE LA VIDA.
- Published in:
- Revista de Economía Aplicada, 2013, v. 21, n. 61, p. 97
- By:
- Publication type:
- Article
The oncolytic adenovirus VCN-01 promotes anti-tumor effect in primitive neuroectodermal tumor models.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-51014-1
- By:
- Publication type:
- Article
Oncolytic Adenoviruses Armed with Thymidine Kinase Can Be Traced by PET Imaging and Show Potent Antitumoural Effects by Ganciclovir Dosing.
- Published in:
- PLoS ONE, 2011, v. 6, n. 10, p. 1, doi. 10.1371/journal.pone.0026142
- By:
- Publication type:
- Article
Codon Usage and Adenovirus Fitness: Implications for Vaccine Development.
- Published in:
- Frontiers in Microbiology, 2021, v. 11, p. N.PAG, doi. 10.3389/fmicb.2021.633946
- By:
- Publication type:
- Article
Bivariate Mixed Poisson and Normal Generalised Linear Models with Sarmanov Dependence—An Application to Model Claim Frequency and Optimal Transformed Average Severity.
- Published in:
- Mathematics (2227-7390), 2021, v. 9, n. 1, p. 73, doi. 10.3390/math9010073
- By:
- Publication type:
- Article
The History of the Insurance Market in Spain.
- Published in:
- Assurances et Gestion des Risques, 2013, v. 81, n. 1/2, p. 103, doi. 10.7202/1091800ar
- By:
- Publication type:
- Article
Predicting MHC I restricted T cell epitopes in mice with NAP-CNB, a novel online tool.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-89927-5
- By:
- Publication type:
- Article
Effect of Transgene Location, Transcriptional Control Elements and Transgene Features in Armed Oncolytic Adenoviruses.
- Published in:
- Cancers, 2020, v. 12, n. 4, p. 1034, doi. 10.3390/cancers12041034
- By:
- Publication type:
- Article
Antitumor‐specific T‐cell responses induced by oncolytic adenovirus ONCOS‐102 (AdV5/3‐D24‐GM‐CSF) in peritoneal mesothelioma mouse model.
- Published in:
- Journal of Medical Virology, 2018, v. 90, n. 10, p. 1669, doi. 10.1002/jmv.25229
- By:
- Publication type:
- Article
Gold Nanoparticle-Assisted Virus Formation by Means of the Delivery of an Oncolytic Adenovirus Genome.
- Published in:
- Nanomaterials (2079-4991), 2020, v. 10, n. 6, p. 1183, doi. 10.3390/nano10061183
- By:
- Publication type:
- Article
Novel combinatorial therapy of oncolytic adenovirus AdV5/3-D24-ICOSL-CD40L with anti PD-1 exhibits enhanced anti-cancer efficacy through promotion of intratumoral T-cell infiltration and modulation of tumour microenvironment in mesothelioma mouse model.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1259314
- By:
- Publication type:
- Article
Correction: Characterization of the Antiglioma Effect of the Oncolytic Adenovirus VCN-01.
- Published in:
- 2016
- By:
- Publication type:
- Correction Notice
Joint Modelling of Survival and Emergency Medical Care Usage in Spanish Insureds Aged 65+.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
Characterization of the Antiglioma Effect of the Oncolytic Adenovirus VCN-01.
- Published in:
- PLoS ONE, 2016, v. 11, n. 1, p. 1, doi. 10.1371/journal.pone.0147211
- By:
- Publication type:
- Article
Immunostimulatory gene therapy targeting CD40, 4-1BB and IL-2R activates DCs and stimulates antigen-specific T-cell and NK-cell responses in melanoma models.
- Published in:
- Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04374-2
- By:
- Publication type:
- Article